- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Hella Janssen
Total 3324 results
-
Adrian VellaCompleted
-
Cheju Halla General HospitalCompletedPainKorea, Republic of
-
Cheju Halla General HospitalCompleted
-
Cheju Halla General HospitalCompletedPancreatic Cancer | Cholangiocarcinoma | Pancreatitis | CholedocholithiasisKorea, Republic of
-
Cheju Halla General HospitalCompletedTolerance | Disorder of Upper Gastrointestinal Tract | C.Medical Procedure; Digestive SystemKorea, Republic of
-
Cheju Halla General HospitalCompleted
-
Cheju Halla General HospitalCompletedAcute Calculous Cholecystitis | Acute Acalculous CholecystitisKorea, Republic of
-
Janssen-Cilag Farmaceutica Ltda.Janssen Korea, Ltd., KoreaNo longer availableMyelodysplastic SyndromesHong Kong, Brazil, Thailand
-
Janssen Cilag S.A.S.RecruitingLeukemia, Lymphocytic, Chronic, B-CellFrance
-
Janssen Pharmaceutical K.K.RecruitingGeneralized Pustular Psoriasis | Erythrodermic PsoriasisJapan
-
Janssen Pharmaceutical K.K.RecruitingX-Linked Retinitis PigmentosaJapan
-
Janssen Pharmaceutical K.K.RecruitingPulmonary Arterial HypertensionJapan
-
Janssen Pharmaceutical K.K.Active, not recruiting
-
Janssen Pharmaceutical K.K.Active, not recruiting
-
Janssen Pharmaceutical K.K.CompletedX-Linked Retinitis PigmentosaJapan
-
Janssen Pharmaceutical K.K.Active, not recruiting
-
Janssen Pharmaceutical K.K.Active, not recruiting
-
Janssen Pharmaceutical K.K.Terminated
-
Janssen Pharmaceutical K.K.CompletedWaldenstrom MacroglobulinemiaJapan
-
Janssen Pharmaceutical K.K.TerminatedStomach Neoplasms | Esophageal NeoplasmsJapan
-
BayerJanssen, LPCompleted
-
Janssen Cilag S.A.S.Completed
-
Janssen Pharmaceutical K.K.Completed
-
Janssen-Cilag Ltd.CompletedMultiple MyelomaBrazil, Argentina, Mexico, Colombia, Panama
-
Janssen Pharmaceutical K.K.Completed
-
Janssen-Cilag Ltd.CompletedDepressive Disorder, Treatment-ResistantPortugal, Germany, Italy, Belgium, Spain, United Kingdom, Netherlands
-
Janssen-Cilag, S.A.CompletedDepressive Disorder, Treatment-ResistantBrazil, Argentina, Mexico, Colombia
-
Janssen Pharmaceutical K.K.Completed
-
Janssen-Cilag G.m.b.HCompleted
-
Janssen Pharmaceutical K.K.CompletedTuberculosis, Multidrug-ResistantJapan
-
Janssen Pharmaceutical K.K.Completed
-
Janssen Pharmaceutical K.K.Withdrawn
-
Janssen Pharmaceutical K.K.Completed
-
Janssen Biotech, Inc.Completed
-
Janssen Pharmaceutical K.K.Completed
-
Janssen Pharmaceutical K.K.Completed
-
Janssen-Cilag G.m.b.HCompletedHuman Immunodeficiency Virus (HIV)Germany
-
Janssen Biotech, Inc.Terminated
-
Janssen Biotech, Inc.Completed
-
Janssen Pharmaceutical K.K.Completed
-
Janssen Pharmaceutical K.K.Completed
-
Janssen Pharmaceutical K.K.Completed
-
Janssen Pharmaceutical K.K.CompletedRespiratory Syncytial Virus InfectionsJapan
-
Janssen-Cilag Ltd.Completed
-
Janssen Pharmaceutical K.K.CompletedPain | Postoperative PainJapan
-
Janssen Pharmaceutical K.K.CompletedDermatitis, AtopicJapan
-
Janssen Biotech, Inc.TerminatedCrohn's DiseaseUnited States, France, United Kingdom, Germany, Belgium, Australia, Israel, Canada, Netherlands, New Zealand, Czech Republic, Austria, Poland, Hungary
-
Janssen-Cilag B.V.CompletedMultiple Myeloma | Hematological NeoplasmsNetherlands
-
Janssen-Cilag G.m.b.HCompleted
-
Janssen Pharmaceutical K.K.Completed